Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02423161 · ClinicalTrials.gov registry record
PIONEER: Intraoperative and Perioperative OCT Study
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 750
- Enrollment target
NCT02423161: Completed study, sponsored by The Cleveland Clinic.
NCT02423161 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02423161 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
OCT provides high-resolution information regarding the anatomic structure of the tissues of the eye in a 2-dimensional and 3-dimensional view. Much of this information is not able to be recognized by a clinician. Utilizing this information during surgery will allow for ophthalmic surgeons to better understand how surgical procedures impact the anatomic structure of the eye.
Primary Outcome
Defined as percentage of cases where OCT was successfully able to be obtained during surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-08 |
What the finished NCT02423161 record still lists
NCT02423161 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02423161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02423161 about?
NCT02423161 is a clinical study titled "PIONEER: Intraoperative and Perioperative OCT Study". OCT provides high-resolution information regarding the anatomic structure of the tissues of the eye in a 2-dimensional and 3-dimensional view. Much of this information is not able to be recognized by a clinician. Utilizing this information during surgery will allow for ophthalmic surgeons to better ...
What is the current status of trial NCT02423161?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2011-08. Estimated completion is 2017-08.
Who is sponsoring clinical trial NCT02423161?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia